Categories: News

Curcumin Done Right: Nuvothera Launches Next-Gen, Super-Micronized Turmeric Supplement

FORT WORTH, Texas, April 9, 2019 /PRNewswire/ — Nuvothera announced the launch of its Super-Micronized Turmeric Curcumin supplement for consumers seeking to reduce their dependence on prescription medicines.

The last few years, consumers have increasingly purchased turmeric supplements based on reported benefits, including diminished joint pain, improved brain function, lower risk of heart disease and cancer, thwarting Alzheimer’s disease, and even anti-aging effects. Today’s market primarily includes turmeric supplements with products composed of 95 percent curcumin, the most active ingredient in turmeric.

The ample science backing these benefits often indicates life-changing benefits for people wanting help to support healthy joints and mobility*.

Nuvothera CEO Arthur Clapp has many years of experience developing botanically-based alternatives to pharmaceutical treatments. He learned that the curcuminoids in turmeric, used as a natural anti-inflammatory and healing agent for thousands of years, worked as well as some well-established non-prescription OTC products to help support joint health and mobility*.

However, to work well orally, turmeric or curcumin needs to be absorbed effectively by the digestive tract. Clapp ultimately purchased and tried over 4 dozen turmeric supplement brands, and, while a few showed positive results at their recommended dosages, none delivered the benefits he had expected. The reason, Clapp discovered, rested with poor bioavailability.

Curcumin is hydrophobic and resistant to absorption in the bloodstream when taken orally; nearly all curcumin found in natural turmeric powder (approximately 97 percent) passes ineffectively through the body. Clapp worked with scientists to find a better way.

“Open up a typical curcumin capsule and pour it in a glass of water,” Clapp suggests. “You’ll see the contents float on top of the water. When you pour our Super-Micronized Turmeric Curcumin on water, it dissolves instantly. That’s the difference particle size makes. Our turmeric curcumin supplement absorbs easily and is selectively taken up by our bodies without the need for additional absorption enhancers.”

“Our Super-Micronized Turmeric Curcumin excels in so many ways beyond conventional curcumin options,” says Clapp.

Nuvothera Super-Micronized Turmeric Curcumin sells for $30 to $40 per bottle. It is available from the Nuvothera website, through Amazon, and other outlets.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Contact for media inquiries:
Beatriz Arana, 34 634 691 473
Beatriz.arana@energiacommunications.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/curcumin-done-right-nuvothera-launches-next-gen-super-micronized-turmeric-supplement-300827911.html

SOURCE Nuvothera

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

21 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

3 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

3 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

3 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

3 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

3 hours ago